<DOC>
	<DOCNO>NCT02208336</DOCNO>
	<brief_summary>This research trial study electronic medical record review monitoring effect adherence myelosuppression morbidity patient newly diagnose brain tumor receive temozolomide radiation therapy . Myelosuppression condition bone marrow activity decrease , result few red blood cell , white blood cell , platelet side effect cancer treatment . Morbidity term refers symptom disease medical problem cause treatment . Monitoring patient ' electronic medical record compare side effect , myelosuppression morbidity , treatment adherence may way enhance patient care organize data medical staff .</brief_summary>
	<brief_title>Electronic Medical Record Review Monitoring Effects Adherence Myelosuppression Morbidity Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide Radiation Therapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I. Retrospectively measure frequency nonadherence establish monitor guideline target patient population . II . Retrospectively assess impact nonadherence event myelosuppression severity patient morbidity . III . Prospectively measure effect automate notification program adherence rate . SECONDARY OBJECTIVES : I . Quantify time saving realize patient care staff use program . II . Quantify number patient care intervention directly result automate monitoring notification program . OUTLINE : Patients ' electronic medical record review adherence , severe myelosuppression , patient morbidity retrospectively prospectively .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>RETROSPECTIVE : All patient see Dr . Lesser 's clinic receive concurrent temozolomide radiation therapy follow adjuvant temozolomide newly diagnose malignant glioma 01/01/07 03/31/2010 analyzed PROSPECTIVE : All patient see Dr . Lesser 's clinic receive concurrent temozolomide radiation therapy follow adjuvant temozolomide newly diagnose malignant glioma construction system end study Patients participate clinical trial deviation nonstandard therapy engender similar monitoring risk evaluate study case case basis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>